Access Bio, Inc. (KOSDAQ:950130)
South Korea · Delayed Price · Currency is KRW 2,340.00
-5.00 (-0.21%)
Aug 11, 2026, 3:30 PM KST
Access Bio Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 14,939 | 31,255 | 112,463 | 348,643 | 1,033,863 | 505,112 |
Revenue Growth | -84.83% | -72.21% | -67.74% | -66.28% | 104.68% | 314.71% |
Gross Profit Gross Profit Growth | -33,680 | -24,767 | 53,266 | 169,878 | 819,375 | 395,965 |
Operating Income Operating Income Growth | -67,240 | -64,193 | -12,602 | 21,922 | 468,238 | 259,669 |
Net Income Net Income Growth | -83,168 | -82,118 | -347.58 | -3,173 | 346,670 | 189,690 |
Earnings Per Share EPS Growth | -2364.02 | -2332.00 | -14.00 | -93.91 | 9212.00 | 5127.00 |
EPS Growth | - | - | - | - | 79.68% | 268.32% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 376,459 | 402,997 | 454,847 | 346,976 | 498,714 | 200,333 |
Total Debt Total Debt Growth | 43,703 | 42,844 | 66,000 | 73,141 | 75,421 | 70,081 |
Net Cash (Debt) Net Cash Growth | 332,756 | 360,153 | 388,847 | 273,835 | 423,293 | 130,251 |
Net Cash Growth | -11.74% | -7.38% | 42.00% | -35.31% | 224.98% | 4128.83% |
Net Cash Per Share Net Cash Per Share Growth | 9458.43 | 10227.65 | 15662.31 | 8105.08 | 11183.97 | 3491.51 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -70,603 | -29,183 | 19,904 | -103,882 | 369,198 | 163,477 |
Capital Expenditures CapEx Growth | -984.22 | -1,791 | -2,051 | -18,615 | -18,753 | -34,079 |
Free Cash Flow Free Cash Flow Growth | -71,587 | -30,974 | 17,853 | -122,498 | 350,444 | 129,398 |
Free Cash Flow Growth | - | - | - | - | 170.83% | 412.35% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | -225.45% | -79.24% | 47.36% | 48.73% | 79.25% | 78.39% |
Operating Margin | -450.09% | -205.39% | -11.21% | 6.29% | 45.29% | 51.41% |
Pretax Margin | -728.08% | -337.16% | -0.13% | -1.69% | 44.85% | 50.83% |
Profit Margin | -556.72% | -262.74% | -0.31% | -0.91% | 33.53% | 37.55% |
FCF Margin | -479.19% | -99.10% | 15.88% | -35.14% | 33.90% | 25.62% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 1.20 | 3.00 |
Forward PE | - | 22.67 | 22.67 | 22.67 | 22.67 | 22.67 |
P/FCF Ratio | - | - | 10.23 | - | 1.18 | 4.40 |
PS Ratio | 5.52 | 4.28 | 1.62 | 0.87 | 0.40 | 1.13 |